Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 10, 2006, Pages 4175-4178

  Dardano, Angela ^a   Ghiadoni, Lorenzo ^a   Plantinga, Yvonne ^a   Caraccio, Nadia ^a   Bemi, Alessia ^a   Duranti, Emiliano ^a   Taddei, Stefano ^a   Ferrannini, Ele ^a   Salvetti, Antonio ^a   Monzani, Fabio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; C REACTIVE PROTEIN; FERRIC OXIDE; GLYCERYL TRINITRATE; INTERLEUKIN 6; LIOTHYRONINE; LIPID PEROXIDE; RECOMBINANT THYROTROPIN; THYROGLOBULIN; THYROTROPIN; THYROXINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; IN VIVO STUDY; INFLAMMATION; MALE; OXIDATIVE STRESS; PATIENT MONITORING; PRIORITY JOURNAL; THYROID CARCINOMA; TUMOR DIFFERENTIATION; ULTRASOUND; VASODILATATION;

EID: 33749575290     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-0440     Document Type: Article

References (20)

1. Cappola AR, Ladenson PW 2003 Hypothyroidism and atherosclerosis. J Endocrinol Metab 88:2438-2444
2. Monzani F, Dardano A, Caraccio N 2006 Does treating subclinical hypothyroidism improve markers of cardiovascular risk? Treat Endocrinol 5:65-81
3. Heitzer T, Schlinzig T, Krohn K Meinertz T, Munzel T 2001 Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 104:2673-2678
4. Luscher TF, Vanhoutte PM 1990 The endothelium: modulator of cardiovascular function. Boca Raton, FL: CRC Press; 1-215
5. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A 1998 Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97:2222-2229
6. Faulx MD, Wright AT, Hoit BD 2003 Detection of endothelial dysfunction with brachial artery ultrasound scanning. Am Heart J 145:943-951
7. Lekakis J, Papamichael C, Alevizaki M, Piperingos G, Marafelia P, Mantzos J, Stamatelopoulos S, Koutras DA 1997 Flow-mediated, endothelium dependent vasodilation is impaired in subjects with hypohtyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 7:411-414
8. Whetsell M, Bagriacik EU, Seetharamaiah GS, Prabhakar BS, Klein JR 1999 Neuroendocrine-induced synthesis of bone marrow-derived cytokines with inflammatory immunomodulating properties. Cell Immunol 192:159-166
9. Drvota V, Janson A, Norman C, Sylven C, Haggblad J, Bronnegard M, Marcus C 1995 Evidence for the presence of functional thyrotropin receptor in cardiac muscle. Biochem Biophys Res Commun 211:426-431
10. Selliti DF, Dennison D, Akamizu T, Doi AS, Kohn LD, Koshiyama H 2000 Thyrotropin regulation of cyclic adenosine monophoshate production in human coronary artery smooth muscle cells. Thyroid 10:219-225
11. Donnini D, Ambesi-Impiombato FS, Curcio F 2003 Thyrotropin stimulates production of procoagulant and vasodilatative factors in human aortic endothelial cells. Thyroid 13:517-521
12. Antunes TT, Gagnon AM, Bell A, Sorisky A 2005 Thyroid-stimulating hormone stimulates interleukin-6 release from 3T3-L1 adipocytes through a cAMP-protein kinase A pathway. Obes Res 13:2066-2071
13. Wang HC, Dragoo J, Zhou O, Klein JR 2003 An intrinsic thyrotropin-mediated pathway of TNF-α production by bone marrow cells. Blood 101:119-123
14. Giusti M, Valenti S, Guazzini B, Molinari E, Cavallero D, Augeri C, Minuto F 2003 Circulating nitric oxide is modulated by recombinant human TSH administration during monitoring of thyroid cancer remnant. J Endocrinol Invest 26:1192-1197
15. Beux F, Carmassi S, Salvetti MV, Ghiadoni L, Huang Y, Taddei S, Salvetti A 2001 Automatic evaluation of arterial diameter variation from vascular echographic images. Ultrasound Med Biol 27:1621-1629
16. Benzie IFF, Strain JJ 1996 The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal Biochem 239:70-76
17. Weetman AP, Bright-Thomas R, Freeman M 1990 Regulation of interleukin-6 release by human thyrocytes. J Endocrinol 127:357-361
18. Wolfram RM, Budinsky AC, Palumbo B, Palumbo R, Sinzinger H 2002 Radioiodine therapy induces dose-dependent in vivo oxidation injury: evidence by increased isoprostane 8-epi-PGF(2α). J Nucl Med 43:1254-1258
19. Ballardin M, Barsacchi R, Bodei L, Caraccio N, Cristofani R, Di Martino F, Ferdeghini M, Kusmic C, Madeddu G, Monzani F, Rossi AM, Sbrana I, Spanu A, Traino C, Barale R 2004 Oxidative and genotoxic damage after radio-iodine therapy of Graves' hyperthyroidism. Int J Radiat Biol 80:209-216
20. Licinio J, Prolo P, McCann SM, Wong ML 1999 Brain iNOS: current understanding and clinical implications. Mol Med Today 5:225-232